Description

C-[4-(3,5-Dimethyl-Phenyl)-Tetrahydro-Pyran-4-Yl]-Methylamine is a high-purity, advanced pharmaceutical intermediate characterized by its unique molecular scaffold combining a tetrahydro-pyran ring with a dimethyl-phenyl substituent. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex, chiral building blocks. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of central nervous system (CNS) agents, antiviral drugs, and other specialized small-molecule therapies.

Application

• Pharmaceutical Intermediate: Serves as a key chiral building block in the multi-step synthesis of novel Active Pharmaceutical Ingredients (APIs).
• Drug Discovery & Medicinal Chemistry: Used in research and development for constructing complex molecular libraries and lead optimization candidates.
• CNS-Active Compound Synthesis: A critical precursor in the development of potential therapeutics targeting neurological and psychiatric disorders.
• Antiviral Drug Development: Employed in the synthesis of experimental compounds with antiviral mechanisms of action.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.
• Academic Research: Utilized in university and institutional labs for studying organic synthesis methodologies and structure-activity relationships (SAR).

Basic Information

Product Name	C-[4-(3,5-Dimethyl-Phenyl)-Tetrahydro-Pyran-4-Yl]-Methylamine
CAS No.	919017-11-1
Molecular Formula	C15H23NO
Molecular Weight	233.35 g/mol
Synonyms	4-[(3,5-Dimethylphenyl)(methylamino)methyl]tetrahydro-2H-pyran-4-ol (Tautomer); 4-(Aminomethyl)-4-(3,5-dimethylphenyl)tetrahydro-2H-pyran; (4-(3,5-Dimethylphenyl)tetrahydro-2H-pyran-4-yl)methanamine; 919017-11-1; C-[4-(3,5-Dimethyl-Phenyl)-Tetrahydro-Pyran-4-Yl]-Methylamine; 4-(3,5-Dimethylphenyl)tetrahydro-2H-pyran-4-ylmethanamine
EINECS	Contact for details

Quality Control

Our C-[4-(4-(3,5-Dimethyl-Phenyl)-Tetrahydro-Pyran-4-Yl]-Methylamine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, GC, NMR, and mass spectrometry, to ensure high chemical purity and structural identity. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all relevant specifications. Our production adheres to cGMP guidelines where applicable, ensuring consistency and reliability for critical pharmaceutical R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at controlled room temperature (15-25°C). The product is hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere to prevent degradation. Keep away from strong acids and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.